$15.37
al cierre: Nov 4 EDT
$15.22
-0.15-0.98%
Pre-comercialización: 7:59 AM EDT
Comments
Loading...
Orientación y previsiones
ADMA Biologics emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/06/2025 | ADMA | ADMA Biologics | FY | 2026 | — | — | — | $500.00M | $625.00M | $638.85M | |
08/06/2025 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $500.00M | $625.00M | $505.82M | |
05/07/2025 | ADMA | ADMA Biologics | FY | 2026 | — | — | — | $625.00M | — | $600.68M | |
05/07/2025 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $500.00M | — | $496.37M | |
03/03/2025 | ADMA | ADMA Biologics | FY | 2026 | — | — | — | $605.00M | — | — | |
03/03/2025 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $490.00M | — | $482.41M | |
01/13/2025 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $485.00M | — | $486.79M | |
01/13/2025 | ADMA | ADMA Biologics | FY | 2026 | — | — | — | $600.00M | — | — | |
01/13/2025 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $417.00M | $425.00M | $423.19M | |
11/07/2024 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $465.00M | — | $459.22M | |
11/07/2024 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $415.00M | — | $406.09M | |
08/08/2024 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $400.00M | — | $357.50M | |
08/08/2024 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $445.00M | — | $414.48M | |
05/09/2024 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $355.00M | — | $333.87M | |
05/09/2024 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $410.00M | — | $389.87M | |
02/28/2024 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $330.00M | — | $315.30M | |
02/28/2024 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $380.00M | — | — | |
01/08/2024 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $256.00M | $258.00M | $252.79M | |
01/08/2024 | ADMA | ADMA Biologics | Q4 | 2023 | — | — | — | $72.00M | $74.00M | $68.49M | |
11/08/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $335.00M | — | — | |
11/08/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $290.00M | — | $278.40M | |
11/08/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $250.00M | — | $243.06M | |
08/09/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $275.00M | — | $262.00M | |
08/09/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $240.00M | — | $226.03M | |
08/09/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $325.00M | — | — | |
05/10/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $220.00M | — | $212.36M | |
05/10/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | $258.84M | |
05/10/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $300.00M | — | — | |
03/23/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $300.00M | — | — | |
03/23/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | — | |
03/23/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $210.00M | — | $202.75M | |
01/17/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $210.00M | — | $197.45M | |
01/17/2023 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $153.00M | $154.00M | $148.95M | |
01/17/2023 | ADMA | ADMA Biologics | Q4 | 2022 | — | — | — | $49.00M | $50.00M | $43.75M | |
12/06/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $152.00M | $154.00M | $145.86M | |
12/06/2022 | ADMA | ADMA Biologics | Q4 | 2022 | — | — | — | $48.00M | $50.00M | $40.66M | |
11/09/2022 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | — | |
11/09/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $145.00M | $145.00M | $134.39M | |
08/10/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $130.00M | — | $131.92M | |
08/10/2022 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | — | |
08/10/2022 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $300.00M | — | — | |
05/11/2022 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $300.00M | $300.00M | — | |
05/11/2022 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | $250.00M | — | |
05/11/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $130.00M | — | $128.50M | |
03/24/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $125.00M | — | $112.77M | |
01/19/2022 | ADMA | ADMA Biologics | Q4 | 2021 | — | — | — | $26.00M | $26.00M | $21.76M | |
01/19/2022 | ADMA | ADMA Biologics | FY | 2021 | — | — | — | $81.00M | $81.00M | $76.27M | |
03/25/2021 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | — |
PREGUNTAS FRECUENTES
¿Cuál es la orientación más reciente de ADMA Biologics (ADMA)?
En los últimos meses no se han comunicado orientaciones específicas de ventas o beneficios para ADMA Biologics.
Explora orientación y previsión sobre todos los valores.